|
WO2020214799A1
|
|
Injectable triamcinolone formulations
|
|
US2019269702A1
|
|
Compositions and methods for treating noninfectious uveitis
|
|
WO2018111862A1
|
|
Systems and methods for delivering drugs to retinal tissue
|
|
CN110177527A
|
|
The device and method of insertion depth for regulating agent delivering needle
|
|
MX2018013502A
|
|
Systems and methods for ocular drug delivery.
|
|
CA3062845A1
|
|
Systems and methods for ocular drug delivery
|
|
WO2017190142A1
|
|
Formulations and methods for reduction of intraocular pressure
|
|
WO2017139375A1
|
|
Ocular injection kit, packaging, and methods of use
|
|
WO2017120601A1
|
|
Methods and devices for treating posterior ocular disorderswith aflibercept and other biologics
|
|
WO2017120600A1
|
|
Compositions and methods of treating wet age-related macular degeneration
|
|
CN106794321A
|
|
Variable-diameter intubation and for controlling the method to the insertion depth of drug delivery
|
|
CN107072765A
|
|
Method and apparatus for ocular disorders after treatment
|
|
US2016106584A1
|
|
Apparatus and methods for drug delivery using multiple reservoirs
|
|
KR20160005735A
|
|
Apparatus and methods for ocular injection
|
|
CN104884049A
|
|
Methods and devices for the treatment of ocular diseases in human subjects
|
|
WO2014036009A1
|
|
Apparatus and methods for drug delivery using microneedles
|
